Results 91 to 100 of about 2,302 (210)

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

, 2006
Cardiovascular events (CVEs) are the leading cause of death in chronic hemodialysis patients. Results of trials in non-end-stage renal disease (ESRD) patients cannot be extrapolated to patients with ESRD.
Kessler, M., Grünfeld, J.P., Leizorovicz, A., Lechat, P., Lechat, A, Lehert, Philippe, Thuilliez, C., Zannad, F., Leizorovicz, C, Thuilliez, C, Grünfeld, Jp, Lehert, P., for the Fosidial Investigators,, Grunfeld, J-P, Kessler, M   +14 more
core   +1 more source

Fozinopril in the treatment of cardiorenal syndrome in chronic cardiac failure

Терапевтический архив, 2009
Renal dysfunction is an independent risk factor of chronic cardiac failure (CCF) and death due to this disease. CCF patients are elderly patients with diabetes mellitus, arterial hypertension and long-term chronic cardiac insufficiency.
S N Tereshchenko, I V Zhirov, S N Tereschenko, I V Zhirov   +3 more
doaj  

Método de cromatografía líquida de alta resolución para la determinación simultánea de fosinopril sódico e hidroclorotiazida en formulaciones de comprimidos

, 2006
A simple, specifi c, accurate and precise reversed phase HPLC method with UV detection for the simultaneous determinationof fosinopril sodium and hydrohclorthiazide in pharmaceutical formulations was developed.
THAKKER, AJ, MASHRU, RC, SUTARIYA, VB
core  

Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria

, 2005
Background and Purpose-Elevated urinary albumin excretion (UAE) is associated with an increased carotid intimamedia thickness (IMT). Because angiotensin-converting enzyme inhibitors as well as statins have been shown to lower UAE and the progression of ...
van Gilst, WH, Gans, ROB; id_orcid, Hillege, HL, Gans, ROB, Asselbergs, FW, de Jong, PE, van Roon, AM, Smit, AJ   +7 more
core   +1 more source

Fosinopril

Revista de Medicina de la Universidad de Navarra, 2016
E.G. Quetglas, M. Simón, J. Honorato
openaire   +2 more sources

Insulin receptor number in arterial hypertension - Response to treatment with fosinopril or atenolol

, 1998
Human insulin receptor (hINR) number and its response to medical treatment was evaluated in 14 male controls and 40 male hypertensive patients. Twenty patients treated with fosinopril (10 to 20 mg daily orally) comprised Group A and 20 treated with ...
Votteas, V., Kyriakidis, M., T Makris, Triposkiadis, F., Krespi, P., Hatzizaharias, A., Makris, T.   +6 more
core   +1 more source

Determination of Fosinopril in pharmaceutical formulation containing Hydrochlorothiazide by multiwave- lenght UV spectrophotometry

, 1995
A sensitive, simple, rapid and precise method for the simultaneous detn. of fosinopril (FOS) and hydrochlorothiazide (HCT) in pharmaceutical formulations was presented. These active ingredients were extd. in aq. soln.
D. Marini, MAGRI', Antonio, MAGRI', Andrea, F. Balestrieri   +3 more
core   +1 more source

Conceptual approaches to cerebral blood flow correction in postmenopausal women with arterial hypertension

Кардиоваскулярная терапия и профилактика, 2005
Aim. To assess cerebral blood flow and cholesterol (CH) metabolism in postmenopausal women with arterial hypertension (AH); to evaluate dynamics of cerebral blood flow and lipid profile during 6-month antihypertensive and hypolipidemic therapy.
V. V. Yakusevich, M. E. Mozeyko, N. V. Sudareva   +2 more
doaj  

A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease

, 2001
OBJECTIVE: To investigate in a random comparison the capacity of an angiotensin converting enzyme inhibitor (fosinopril), and that of a long-acting dihydropiridine (nifedipine GITS) to modify the decay in renal function in patients with primary renal ...
Ruilope, L.M. (Luis M.), Aljama, P. (P.), Diez-Martinez, J. (Javier), Marin, R. (Rafael), Aranda, P. (P.), Segura, J. (Julián)   +5 more
core  

Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.

, 2005
The differences between long-acting dihydropyridines and angiotensin-converting enzyme inhibitors with regard to their long-term effects on 24-h heart rate variability (HRV) and left ventricular (LV) mass are less clear in mild-to-moderate essential ...
Koylan, N, Atilgan, D, Bilge, AK, Meric, M, Ozcan, M, Tukek, Tufan, Ozben, B   +6 more
core   +1 more source